173 related articles for article (PubMed ID: 33656733)
1. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Heidari-Beni F; Vahedian-Azimi A; Shojaei S; Rahimi-Bashar F; Shahriary A; Johnston TP; Sahebkar A
Adv Exp Med Biol; 2021; 1321():277-286. PubMed ID: 33656733
[TBL] [Abstract][Full Text] [Related]
2. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.
Shen Y; Cheng C; Zheng X; Jin Y; Duan G; Chen M; Chen S
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34207689
[No Abstract] [Full Text] [Related]
3. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
Vazzana N; Dipaola F; Ognibene S
Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
[TBL] [Abstract][Full Text] [Related]
6. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
[TBL] [Abstract][Full Text] [Related]
7. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.
Abadi MSS; Taheri E; Raesi A; Arjmand MH; Kheirii S; Shahinfard N; Habibi Z
Infect Disord Drug Targets; 2022; 22(3):e070122200097. PubMed ID: 34994319
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.
Mahittikorn A; Kotepui KU; Mala W; Wilairatana P; Kotepui M
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141662
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract][Full Text] [Related]
11. Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis.
Wei S; Wang L; Lin L; Liu X
Virol J; 2023 May; 20(1):92. PubMed ID: 37158904
[TBL] [Abstract][Full Text] [Related]
12. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
Lugito NPH
Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
[TBL] [Abstract][Full Text] [Related]
13. Effects of procalcitonin on antimicrobial treatment decisions in patients with coronavirus disease 2019 (COVID-19).
Conlon ASC; Chopra Z; Cahalan S; Cinti S; Rao K
Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1314-1320. PubMed ID: 36330692
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review.
Ahmed S; Jafri L; Hoodbhoy Z; Siddiqui I
Indian J Crit Care Med; 2021 Jan; 25(1):77-84. PubMed ID: 33603306
[TBL] [Abstract][Full Text] [Related]
15. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
Atallah NJ; Warren HM; Roberts MB; Elshaboury RH; Bidell MR; Gandhi RG; Adamsick M; Ibrahim MK; Sood R; Bou Zein Eddine S; Cobler-Lichter MJ; Alexander NJ; Timmer KD; Atallah CJ; Viens AL; Panossian VS; Scherer AK; Proctor T; Smartt S; Letourneau AR; Paras ML; Johannes S; Wiemer J; Mansour MK
PLoS One; 2022; 17(1):e0262342. PubMed ID: 35025929
[TBL] [Abstract][Full Text] [Related]
16. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis.
Paliogiannis P; Mangoni AA; Dettori P; Nasrallah GK; Pintus G; Zinellu A
Front Public Health; 2020; 8():432. PubMed ID: 32903841
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin is a predictor of disseminated intravascular coagulation in patients with fatal COVID-19.
Asoğlu R; Tibilli H; Afşin A; Türkmen S; Barman HA; Asoğlu E
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11953-11959. PubMed ID: 33275269
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19.
Wolfisberg S; Gregoriano C; Schuetz P
Crit Rev Clin Lab Sci; 2022 Jan; 59(1):54-65. PubMed ID: 34517744
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of interleukin-6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta-analysis.
Yoon JR; Yang SH; Shin YS
Int Orthop; 2018 Jun; 42(6):1213-1226. PubMed ID: 29294147
[TBL] [Abstract][Full Text] [Related]
20. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.
Jeyapalina S; Wei G; Stoddard GJ; Sudduth JD; Lundquist M; Huntsman M; Marquez JL; Agarwal JP
PLoS One; 2023; 18(4):e0284520. PubMed ID: 37068086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
